VEA
ONCE

Virtus ETF Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Virtus ETF Advisers’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,751
Closed -$2.25M – 453
2019
Q1 		$2.25M Buy
19,751
+4,520
+30% +$332K 4.79% 1
2018
Q4 		$596K Buy
15,231
+5,069
+50% +$220K 0.1% 45
2018
Q3 		$554K Buy
10,162
+685
+7% +$46.8K 0.06% 112
2018
Q2 		$784K Sell
9,477
-10,547
-53% -$814K 0.69% 41
2018
Q1 		$1.33M Sell
20,024
-1,172
-6% -$67.7K 1.16% 10
2017
Q4 		$1.09M Buy
21,196
+15,378
+264% +$1.1M 1.37% 8
2017
Q3 		$519K Buy
5,818
+266
+5% +$20.2K 0.07% 85
2017
Q2 		$332K Buy
5,552
+191
+4% +$10.7K 0.05% 96
2017
Q1 		$286K Buy
5,361
+514
+11% +$30.5K 0.05% 141
2016
Q4 		$242K Sell
4,847
-434
-8% -$23.2K 0.07% 152
2016
Q3 		$317K Hold
5,281
– – 0.15% 95
2016
Q2 		$270K Buy
5,281
+30
+0.6% +$1.28K 0.2% 71
2016
Q1 		$155K Buy
+5,251
New +$166K 0.21% 117

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Virtus ETF Advisers's ONCE Position: Q2 2019 in Review

Virtus ETF Advisers sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 19,751 shares — an estimated $2.25M sold.

Virtus ETF Advisers first reported a position in ONCE in Q1 2016 and held it in 13 quarters. The position peaked at $2.25M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Virtus ETF Advisers reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Virtus ETF Advisers sold 19,751 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $2.25M.
  • Virtus ETF Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 13 quarters.
  • Virtus ETF Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $2.25M in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.